Medical News

RSS

Orexo AB reports year-end 2009 financial results

Sales of Abstral continue to show robust growth, with royalty revenues rising sharply during the fourth quarter – up threefold from the preceding quarter. Our partner, ProStrakan, launched during 2009 Abstral in UK, Germany, France, Spain and Greece, and product launches in additional markets are imminent. Sales growth confirms that there is a substantial medical requirement in the case of cancer patients suffering from breakthrough pain.

17 Feb 2010

International Stem Cell's human cornea technology: Clinical-commercial opportunities in Asia and Europe

International Stem Cell Corporation, announced today that multiple international meetings taking place between ISCO’s executive management and researchers and clinicians from commercial entities in both Asia and Europe revealed significant clinical-commercial opportunities for the company’s stem cell-derived human cornea technology in those regions.

17 Feb 2010

Rate of chronic health conditions among children in the U.S. increased from 12.8% to 26.6%

The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study in the February 17 issue of JAMA.

17 Feb 2010

Pacific Biosciences introduces partner program for SMRT DNA sequencing system

Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced the launch of a partner program designed to work with best-in-class organizations providing complementary solutions to its Single Molecule Real Time (SMRT™) DNA sequencing system. The program will help customers rapidly and easily adopt its third-generation DNA sequencing solution into their discovery programs.

17 Feb 2010

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

17 Feb 2010

U.S. decreases troop presence in Haiti

A decreased need for troops has led the U.S. military to reduce its troops from a high of about 20,000 after the earthquake to 13,000, General Douglas Fraser said on Saturday, Agence France-Presse reports. Fraser also said the Haitian government was resuming control of the Port-au-Prince airport during daylight, according to the AFP.

17 Feb 2010

BAC adds affinity resin for AAT purification to GE Healthcare’s range of custom designed media

BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare’s range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare’s Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.

17 Feb 2010

Researchers use new strategy to develop cancer vaccines

Researchers at National Jewish Health and the University of Colorado School of Medicine have used a new strategy to develop cancer vaccines that are remarkably effective in mice. In the February 16 issue of the Proceedings of the National Academy of Sciences, Kimberly Jordan, PhD, Jill Slansky, PhD, and John Kappler, PhD, report that 100 percent of the mice vaccinated with a peptide they developed remained alive and tumor-free for at least 60 days after inoculation with colon cancer cells.

17 Feb 2010

RWJF awards nearly $2M in grants to address childhood obesity epidemic

Seven organizations representing policy-makers from across the country have received a total of nearly $2 million in grants from the Robert Wood Johnson Foundation (RWJF) to help communities increase children's access to affordable healthy foods and opportunities for physical activity.

17 Feb 2010

Migraine is seen more frequently in women with MS than those without: Study

Migraine is seen more frequently in women with multiple sclerosis (MS) than those without, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

17 Feb 2010

Imposing tax on health benefits likely to cause major cuts in health benefits

Since the vast majority of Americans who have health coverage get it through their jobs, one obvious question raised by the health reform legislation pending in Congress is: How might it affect the U.S. employment-based health benefits system?

17 Feb 2010

ECR Pharmaceuticals to promote Urocit-K 15mEq tablets to primary care physicians

Hi-Tech Pharmacal Co., Inc. announced today that its branded marketing subsidiary, ECR Pharmaceuticals will promote Urocit®-K 15mEq, potassium citrate extended release tablets to primary care physicians beginning in April, 2010. Hi-Tech has a license agreement with Mission Pharmacal Company, which will promote the product to Urologists.

17 Feb 2010

Merz Pharma Group completes $5.45 per share cash tender offer for all shares of BioForm Medical

Merz Pharma Group today announced the successful completion of the $5.45 per share cash tender offer for all outstanding shares of BioForm Medical, Inc. made by Merz GmbH & Co. KGaA and its acquisition subsidiary. The tender offer expired at 12:00 midnight, Eastern Standard Time, on February 12, 2010.

17 Feb 2010

Study: Researchers use genomics to decode blueprint of Plasmodium falciparum

Scientists battling malaria have earned a major victory. According to a Nature Genetics study, an international group of researchers has used genomics to decode the blueprint of Plasmodium falciparum - a strain of malaria most resistant to drugs that causes the most deaths around the world.

17 Feb 2010

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel. The patent, entitled "Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use," has a priority date of March 4, 2003 and was issued on January 12, 2010.

17 Feb 2010

MEDecision launches InFrame collaborative HIE service

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today introduced the next generation of its healthcare management technology with the launch of InFrame™, a collaborative health information exchange (HIE) service that enables care delivery organizations to share clinical data — including diagnostic-quality medical images — among themselves and with patients to more effectively drive business and comply with meaningful use criteria.

17 Feb 2010

Covidien's Exalgo NDA: FDA sets new PDUFA action date

Covidien today announced that the U.S. Food and Drug Administration has set a new action date of March 1, 2010, under the Prescription Drug User Fee Act (PDUFA) for the review of the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl) Extended-Release Tablets, (CII).

17 Feb 2010

ITS secures £8.65M Series-A equity funding round extension to fund synthetic flu vaccine study

Immune Targeting Systems (ITS) Limited (“ITS”), one of the leading developers of synthetic vaccines for mutating viruses, today announced it had secured a Series-A equity funding round extension for £8.65m which brings the total Series A financing to £13.15m. The company’s key investors HealthCap (Sweden), London Technology Fund (UK), Novartis Venture Fund (US & Basel) and Truffle Capital (France) are all participating. The round will be kept open until mid-2010 for new potential investors to invest.

17 Feb 2010

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

Covidien, a leading global provider of healthcare products, and the Institute of Atomic Energy in Poland today announced an agreement to augment and further diversify Covidien’s supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).

17 Feb 2010

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

17 Feb 2010

Medical News

Orexo AB reports year-end 2009 financial results

International Stem Cell's human cornea technology: Clinical-commercial opportunities in Asia and Europe

Rate of chronic health conditions among children in the U.S. increased from 12.8% to 26.6%

Pacific Biosciences introduces partner program for SMRT DNA sequencing system

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

U.S. decreases troop presence in Haiti

BAC adds affinity resin for AAT purification to GE Healthcare’s range of custom designed media

Researchers use new strategy to develop cancer vaccines

RWJF awards nearly $2M in grants to address childhood obesity epidemic

Migraine is seen more frequently in women with MS than those without: Study

Imposing tax on health benefits likely to cause major cuts in health benefits

ECR Pharmaceuticals to promote Urocit-K 15mEq tablets to primary care physicians

Merz Pharma Group completes $5.45 per share cash tender offer for all shares of BioForm Medical

Study: Researchers use genomics to decode blueprint of Plasmodium falciparum

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

MEDecision launches InFrame collaborative HIE service

Covidien's Exalgo NDA: FDA sets new PDUFA action date

ITS secures £8.65M Series-A equity funding round extension to fund synthetic flu vaccine study

Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News